newsfilter
← Latest News
Business Wire·

PepGen Announces Pricing of $100 Million Public Offering

PepGen Inc. (NASDAQ:PEPG), a clinical-stage biotechnology company developing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological